IPQ Inside the global regulatory dialogue

FDA Transmits Prescription, Generic and Biosimilar Drug User Fee Proposals to Congress

Jan 16th, 2012

Please Log in to print the full article

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications